期刊文献+

IL-12家族与多发性硬化的研究进展 被引量:2

Research progress of IL-12 families and multiple sclerosis
原文传递
导出
摘要 IL—12家族由结构相似的IL—12和新近发现的IL-23、IL-27组成。这3个细胞因子通过激活初始T细胞或记忆性T细胞诱导出不同的细胞因子表型,在多发性硬化(MS)和实验性自身免疫性脑脊髓炎(EAE)中发挥重要的作用:以前的观点认为IL-12在MS和EAE的发病中起着至关重要的作用,然而,最新发现,IL-23可通过诱导分化Th17细胞产生IL-17,在MS和EAE发病中起着重要的作用。IL-27在EAE和MS的发病过程中发挥双向调节作用.即早期发挥致炎作用,后期发挥抗炎作用。 Cytokine IL-12 and the recently discovered cytokine IL-23 and IL-27, which have a similar structure to cytokine IL-12, combine to form the IL-12 family. These three cytokines activate naive T cells or memory T cells and then induce different cytokine phenotypes and play an important role in the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It was previously believed that only cytokine IL-12 played an important role in multiple sclerosis and experimental autoimmuue encephalomyelitis. However, the latest discovery shows that it is cytokine IL-23, but not IL-12, to produce cytokine IL- 17 through inducing and differentiating Th17 and promote the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Meanwhile, cytokine IL-27 has a dual effect: it induces inflammation at the onset and suppresses inflammation in the advanced stages.
出处 《国际免疫学杂志》 CAS 北大核心 2010年第1期19-22,共4页 International Journal of Immunology
基金 广西自然科学基金资助项目(桂科回0991009)
关键词 IL-12家族 多发性硬化 实验性自身免疫性脑脊髓炎 Interleukin-12 family Muhiple sclerosis Experimental autoimmune encephalomyelitis
  • 相关文献

参考文献20

  • 1董梅,李春岩(审校者).多发性硬化的发病机制[J].国际免疫学杂志,2006,29(2):100-104. 被引量:11
  • 2Kurts C. Th17 cells:a third subset of CD4+ T effector cells involved in organ-specific autoimmunity. Nephrol Dial Transplant, 2008,23 (3) : 816-819. 被引量:1
  • 3Langrish CL,Chen Y,Blumenschein WM,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med ,2005,201 (2) :233-240. 被引量:1
  • 4Ghilardi N,Kljavin N,Chen Q,et al. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J Immunol,2004,172( 5 ) :2827-2833. 被引量:1
  • 5Happel KI, Zheng M,Young E, et al. Cutting edge :roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol,2003,170 (9) :4432-4436. 被引量:1
  • 6Paul R. Mangan, Laurie E. Harrington, Darrell B. O'Quinn, et al. Transforming growth factor-beta induces development of the TH17 lineage. N ature,2006,441 ( 7090 ) :231-234. 被引量:1
  • 7Huber M, Steinwald V, Guralnik A, et al. IL-27 inhibits the development of regulatory T cells via STAT3. Int Immunol,2008,20(2) : 223 -234. 被引量:1
  • 8Pflanz S, Timans JC, Cheung J, et al. IL-27, a Heterodimerie Cytokine Composed of EB13 and p28 Protein, Induces Proliferation of Naive CD4^+ T Cells. Immunity,2002,16(6) :779-790. 被引量:1
  • 9Batten M, Li J, Yi S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol,2006 ,7 (9) :929-936. 被引量:1
  • 10Yoshimura T, Takeda A, Hamano S, et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4^+ T cells versus suppression of proinflammatory cytokine production including IL- 23-induced IL-17 on activated CD4^+ T cells partially through STAT3-dependent mechanism. J Immunol, 2006,177 ( 8 ) : 5377- 5385. 被引量:1

二级参考文献19

  • 1Noseworthy JH.Progress in determining the causes and treatment of multiple sclerosis.Nature,1999,24,399(6738 Suppl):A40-47. 被引量:1
  • 2Chofflon M.Mechanisms of action for treatments in multiple sclerosis:does a heterogeneous disease demand a multi-targeted therapeutic approach? BioDrugs,2005,19(5):299-308. 被引量:1
  • 3Kenealy SJ,Pericak-Vance MA,Haines JL.The genetic epidemiology of multiple sclerosis.J Neuroimmunol,2003,143(1-2):7-12. 被引量:1
  • 4Alotaibi S,Kennedy J,Tellier R,et al.Epstein-Barr virus in pediatric multiple sclerosis.JAMA,2004,291(15):1875-1879. 被引量:1
  • 5Hemmer B,Cepok S,Zhou D,et al.Multiple sclerosis -a coordinated immune attack across the blood brain barrier.Curr Neurovasc Res,2004,1(2):141-150. 被引量:1
  • 6Bilinska M.Multiple stimulation of T lymphocytes in the pathogenesis of multiple sclerosis.Pol Merkuriusz Lek,2003,15(90):570-573. 被引量:1
  • 7Minagar A,Alexander JS.Blood-brain barrier disruption in multiple sclerosis.Mult Scler,2003,9(6):540-549. 被引量:1
  • 8Rudick RA,Sandrock A.Natalizumab:alpha4-integrin antagonist selective adhesion molecule inhibitors for MS.Expert Rev Neurother,2004,4(4):571-580. 被引量:1
  • 9Bar-Or A,Nuttall RK,Duddy M,et al.Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.Brain,2003,126(Pt 12):2738-2749. 被引量:1
  • 10Owens T.The enigma of multiple sclerosis:inflammation and neurodegeneration cause heterogeneous dysfunction and damage.Curr Opin Neurol,2003,16(3):259-265. 被引量:1

共引文献10

同被引文献5

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部